Get started

Trend Lines

Britannia Industries: Strong Support at Long-Term TrendlineBritannia Industries is currently at a significant support level, having touched a four-year long-term trendline. The stock has declined 24% from its all-time high, making it a potential buying opportunity for investors. Fundamental Points for Britannia Industries (2024) Market Capitalization: Approximately ₹1,19,229 crore. P/E Ratio: Around 55.96, indicating a premium valuation. Return on Equity (ROE): Approximately 54.28%, reflecting strong profitability. Dividend Yield: About 1.48%, providing consistent income to investors. Recent Performance: The stock has shown resilience with a recent increase of 3.06% on January 9, 2025.
NSE:BRITANNIA
by DragonFly-Trading
Kalyan Jewelry: Technical Analysis and Investment OutlookFormation of Bat Pattern: Kalyan Jewelry has recently formed a Bat pattern, a bullish reversal pattern that suggests potential price increases in the near future. Strong Support Level: The stock is currently trading at a significant support level around ₹525, which may provide a solid foundation for a price rebound. Decline from All-Time High: The stock has already declined approximately 33% from its all-time high, indicating that it may be undervalued and presenting a buying opportunity for long-term investors. Long-Term Investment Potential: Given the technical indicators and support levels, Kalyan Jewelry appears to be a promising option for long-term investment strategies.
NSE:KALYANKJILLong
by DragonFly-Trading
4
AARTIDRUGS : Swing Pick ( 1:2 RR Trade)#AARTIDRUGS #momentumstock #breakoutstock AARTIDRUGS : Swing Trade >> Good Setup (1: 2 Risk Reward Trade) >> Good Strength in Stock >> Volumes Dried up >> Low PE Stock Swing Traders can lock profit at 10% and keep Trailing Please Boost, comment and follow us for more Learnings. Disc : Charts shared are for learning purpose only, not a Trade recommendation. Do your own research and consult your financial advisor before taking any position.
NSE:AARTIDRUGSLong
by moneyfesttrading
BAJAJ AUTO - Buy for the target 9925/30Technical: => Internal Structure with strong Resistance Breakout done => Expecting to give good upside movement => Estimate target price will be 9925/30 => Stoploss is around 9000 on closing basis In Addition, BAJAJ AUTO PASS ON THE FULL GST REDUCTION BENEFIT TO CUSTOMERS: Bajaj Auto Ltd. has announced it will pass on the benefit of the recent GST reduction to customers across its motorcycle and three-wheeler range. Effective September 22, 2025, The reduction is up to ₹20,000 on two-wheelers and up to ₹24,000 on the three-wheeler range. == EDUCATIONAL PURPOSE ONLY ==
NSE:BAJAJ_AUTOLong
by Kotti_Kals
Nifty - Multi time frame analysis Sep 9Today, the price did not gain strength and moved in the range of 24700 to 24900. And 25000 is a psychological level. This type of nearby support/resistance can give choppy movement unless the price shows strength from the opening. Support levels are 24500, 24600. Resistance levels are 24900, 25000. We can buy if the price opens at support with bullish strength. If the opening is flat, buy above 24820 with the stop loss of 24770 for the targets 24860, 24920, 24980, 25020, and 25080. Sell below 24680 with the stop loss of 24730 for the targets 24640, 24600, 24540, 24500, 24460 and 24420. As per the daily chart, the price is moving in a range, and it also has nearby trendline resistance. Strong movement can happen if the trend line is taken with strength. As per the hour chart, if the price does not gain strength when breaking the range it has formed today, then the expiry will be in range. Expected expiry day range is 24400 to 24900.
NSE:NIFTY
by vanathi
4
Sun Pharma – Double Bottom and Trendline Test AheadChart Summary Sun Pharma’s weekly chart shows a completed W–X–Y corrective structure. Wave W bottomed near ₹1,553.05, followed by a corrective X at ₹1,851.20, and Wave Y terminating at ₹1,556.20. This final Y-leg has unfolded as an abc zigzag, respecting the larger corrective framework. Price Action Highlights A potential structural double bottom has formed around the ₹1,553–₹1,556 zone, hinting at possible exhaustion of the correction. The latest candle is a hammer-like bar, suggesting demand stepped in around support levels. Overhead, a major downtrend resistance line connecting the highs (₹1,960.35) to the swing X (₹1,851.20) remains the decisive breakout level. A clear stop-loss line sits near ₹1,520.40, aligned with the 100% extension of Wave A inside Y. A break below this level invalidates the bullish case. Volume Perspective Recent selling has come with a volume spike, often seen during exhausation selling phases. If volume eases on follow-up candles while price holds above the support zone, it strengthens the case for a reversal. Outlook If price can sustain above the ₹1,553–₹1,556 support cluster and eventually break the trendline resistance, it may confirm the end of the corrective phase and open the door for a new impulsive sequence higher. Failure to hold the stop-loss zone, however, would negate this view and suggest further downside. Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Please do your own research (DYOR) before making any trading decisions.
NSE:SUNPHARMALong
by WaveXplorer
BTC developing a good sell opportunityBTC is moving in range for long time. Now it has shown a displacement after ChoCH and formed a bearish 15m FVG. There may be a good trade at sell side if price approach it. Well there are two trade scenarios are forming. 1. Price moves to 15m FVG and OTE overlap zone. 2. Most probably price will take liquidity of FVG and OTE zone and create MSS in LTF. 3. After breaking trend line it should pullback till FVG/trend line or any newly created OB/FVG. All these combinations are signalling a high probability and high Risk and Reward (1:8) trade scenario. Note – if you liked this analysis, please boost the idea so that other can also get benefit of it. Also follow me for notification for incoming ideas. Also Feel free to comment if you have any input to share. Disclaimer – This analysis is just for education purpose not any trading suggestion. Please take the trade at your own risk and with the discussion with your financial advisor.
DELTAIN:BTCUSD.PShort
by hari_log
VIMTALABS: Parallel Channel & Flag BO, Chart of the WeekNSE:VIMTALABS Explodes 50%: From Parallel Channel Prison to Trendline Freedom Post Q1 FY26 Flag Breakout. Let's analyse it in the "Chart of the Week" As per the Latest SEBI Mandate, this isn't a Trading/Investment RECOMMENDATION nor for Educational Purposes; it is just for Informational purposes only. The chart data used is 3 Months old, as Showing Live Chart Data is not allowed according to the New SEBI Mandate. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions. Price Action Analysis: - Current Price: ₹887.20 (as per chart) - 52-Week Range: ₹252 to ₹903 - Market Cap: ₹3,901 Crores - Recent Performance: Stock has shown exceptional momentum with 171% returns in the past year Volume Spread Analysis: - Breakout Volume: Exceptional volume spike during the August 2025 breakout - Volume Confirmation: Higher volumes on up-moves, lower on corrections - Accumulation Phase: Steady volume during the consolidation phase indicates smart money accumulation Chart Patterns: - Long-term Ascending Trendline: Yellow trendline acting as dynamic support since May 2024 - Parallel Channel Breakout: Stock consolidated in a 6-month parallel channel (₹400-550) from December 2024 to July 2025 - Flag and Pennant Formation: Classic continuation pattern post Q1 FY26 results - Volume Breakout: Massive volume surge accompanying the breakout, confirming genuine momentum Key Technical Levels: - Base Formation: ₹400-450 level established during Dec 2024 - Jul 2025 consolidation - Primary Support: ₹550-600 (previous resistance turned support) - Secondary Support: ₹500 (parallel channel upper boundary) - Immediate Resistance: ₹700-750 (psychological levels) - Final Resistance: ₹900-1000 Fundamental and Sectoral Backdrop: Company Overview: - Contract Research and Testing Organization serving biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, and medical device sectors Financial Performance: - Q1 FY26 Results: Net profit rose 53.83% to ₹19 Crore, sales increased 30.29% to ₹98 crore - Recent Quarter: EBITDA margins at 35.7% - Debt Position: The Company is almost debt-free Sector Dynamics: - CRO/CRAMS Sector: Strong tailwinds from global pharmaceutical outsourcing - Biologics Focus: Company expanding in high-growth biologics testing segment - Regulatory Compliance: Successfully completed US FDA GCP certification Other Highlights: - Consistent revenue growth across quarters - Strong margin expansion and operational efficiency - Debt-free balance sheet providing financial flexibility - Expanding service offerings in high-margin biologics - Beneficiary of the global pharma outsourcing trend Key Risk Factors: - High valuation metrics post recent rally - Dependence on the pharmaceutical sector cycles - Regulatory compliance requirements - Competition from larger CRO players Market Sentiment: - Recent 31% surge to hit a new 52-week high of ₹902, reflecting strong investor interest - Strong institutional interest evidenced by consistent buying - Positive analyst coverage post strong quarterly results Full Coverage on my Newsletter this Week Keep in the Watchlist and DOYR. NO RECO. For Buy/Sell. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FOLLOW for more 👍BOOST if you found it useful. ✍️COMMENT below with your views. Meanwhile, check out my other stock ideas on the right side until this trade is activated. I would love your feedback. As per the Latest SEBI Mandate, this isn't a Trading/Investment RECOMMENDATION nor for Educational Purposes, it is just for Informational purposes only. The chart data used is 3 Months old, as Showing Live Chart Data is not allowed according to the New SEBI Mandate. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:VIMTALABSLong
by Karanshah137
3